AXGN - CIK 0000805928
The table below shows Axogen, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $225.21M | $187.34M | $159.01M | $138.58M | $127.36M | $112.30M |
| Cost of revenue | $57.85M | $45.36M | $37.14M | $29.77M | $22.93M | $21.58M |
| Gross profit | $167.35M | $141.98M | $121.87M | $108.81M | $104.43M | $90.72M |
| R&D | $32.88M | $27.77M | $27.34M | $25.63M | $24.18M | $17.85M |
Axogen, Inc. reported annual revenue of $225.21M for fiscal year 2025. That is up 20.2% from $187.34M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $41.11M (FY 2016) to $225.21M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $44.58M |
| $39.04M |
| $38.41M |
| $40.91M |
| $32.34M |
| $26.40M |
| Operating income | -$7.85M | -$3.29M | -$21.46M | -$29.71M | -$25.42M | -$23.18M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$15.70M | -$9.96M | -$21.72M | -$28.95M | -$26.98M | -$23.79M |
| EPS (diluted) | -$0.34 | -$0.23 | -$0.51 | -$0.69 | -$0.65 | -$0.60 |